Business Introduction We manufacture and supply reliable, high-quality medicines and vaccines to meet patients’ needs and drive our performance. Our network of 37 medicines and vaccines manufacturing sites delivered 1.7 billion packs of m...
Territory to Include, but not limited to, Center City Philadelphia. At GSK, we have already delivered unprecedented change over the past four years, improving R&D, strengthening our leadership, and transforming our commercial execution. W...
Principal Scientist, Oligonucleotide Analytical Chemistry At GSK, we have bold ambitions for patients, aiming to positively impact the health of 2.5 billion people by the end of the decade. Our R&D focuses on discovering and delivering va...
Business Introduction We manufacture and supply reliable, high-quality medicines and vaccines to meet patients’ needs and drive our performance. Our network of 37 medicines and vaccines manufacturing sites delivered 1.7 billion packs of m...
Role Overview: For more than 140 years, GSK has pioneered novel research methods and technologies to help protect people from infectious diseases. Our vaccines portfolio of more than 20 marketed vaccines is the broadest in the industry, h...
Territory to Include, but not limited to, Pittsburgh, PA Role Overview: For more than 140 years, GSK has pioneered novel research methods and technologies to help protect people from infectious diseases. Our vaccines portfolio of more t...
ViiV Healthcare is a global specialty HIV company, the only one that is 100% focused on researching and delivering new medicines for people living with, and at risk of, HIV. ViiV is highly mission-driven in our unrelenting commitment to bei...
Location: Philly or Durham. Must be onsite 2-3 days per week. Reporting to the Senior Director, Market Access Strategy, Oncology Portfolio Lead, the Director, Oncology Market Access Strategy – Access Optimization Lead serves as the enterp...
Business Introduction: GSK remains committed to achieving bold commercial ambitions for the future. By 2031, we aim to deliver £40 billion in annual sales, leveraging our existing strong performance momentum to significantly increase our p...
Business Introduction: GSK remains committed to achieving bold commercial ambitions for the future. By 2031, we aim to deliver £40 billion in annual sales, leveraging our existing strong performance momentum to significantly increase our p...